A. Viúdez

发表

Omics Approaches in Pancreatic Adenocarcinoma

R. Zárate, J. Fernández-Irigoyen, E. Santamaría, 2019, Cancers.

Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy.

V. Arrazubi, R. Vera, F. Arias, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry

P. Jiménez-Fonseca, J. Gallego, R. Serrano, 2019, Clinical and Translational Oncology.

Local recurrence after five years is associated with preoperative chemoradiotherapy treatment in patients diagnosed with stage II and III rectal cancer.

G. Marín, R. Vera, A. Viúdez, 2017, International journal of surgery.

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

E. Bandrés, A. Patiño-García, R. Zárate, 2010, British Journal of Cancer.

Fecal incontinence and radiation dose on anal sphincter in patients with locally advanced rectal cancer (LARC) treated with preoperative chemoradiotherapy: a retrospective, single-institutional study

F. Arias, J. Arraras, A. Viúdez, 2017, Clinical and Translational Oncology.

Combining chemotherapy and targeted therapies in metastatic colorectal cancer.

E. Bandrés, J. García-Foncillas, R. Zárate, 2007, World journal of gastroenterology.

Effects of Adjuvant Oxaliplatin on Anal Function in Locally Advanced Rectal Cancer Treated with Preoperative Chemo-Radiotherapy and Low Anterior Resection

Fern, Ez, A. Viúdez, 2017 .

Unresectable Liver Metastases from Colorectal Cancer and Hepatic Arterial Infusion Chemotherapy: How, When and to Whom?

I. Gil-Bazo, Javier Rodríguez, A. Viúdez, 2009, CardioVascular and Interventional Radiology.

Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.

Y. Nieto, L. Zufía, A. Aldaz, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quality of Life in Spanish advanced non-small-cell lung cancer patients: determinants of global QL and survival analyses

Maite Martínez, R. Vera, J. Arraras, 2016, SpringerPlus.

Pancreatic neuroendocrine tumors: Challenges in an underestimated disease.

R. Vera, A. Viúdez, F. Carvalho, 2016, Critical reviews in oncology/hematology.

Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer

F. García-Bragado, M. J. García-Velloso, F. Arias, 2015, Clinical and Translational Oncology.

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

A. Carrato, R. Salazar, C. García-Girón, 2021, Drugs & Aging.

Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer

M. Alsina, M. P. Lobera, E. Castañón, 2017, Gastric Cancer.

Liver disease induced by radioembolization of liver tumors

B. Sangro, J. Bilbao, I. Sola, 2008, Cancer.

Nab-paclitaxel: a flattering facelift.

M. Hidalgo, R. Vera, A. Viúdez, 2014, Critical reviews in oncology/hematology.

Safety and clinical activity of vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors after programmed cell death 1 inhibitor treatment in patients with metastatic clear cell renal cell carcinoma.

R. Motzer, E. Plimack, M. Voss, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

90Y Microspheres for Other Liver Metastases

J. García-Foncillas, Javier Rodríguez, A. Viúdez, 2008 .

Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus.

I. Arozarena, R. García-Carbonero, J. Capdevila, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Triplet therapy with oxaliplatin, irinotecan, 5-fluorouracil and folinic acid within a combined modality approach in patients with liver metastases from colorectal cancer.

J. García-Foncillas, F. Rotellar, I. Gil-Bazo, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan and mitomycin C (MMC) as salvage therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidine, irinotecan and/or oxaliplatin based chemotherapy.

J. García-Foncillas, A. Viúdez, C. Garrán, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry

F. Rivera, C. Pericay, F. Alvarez-Manceñido, 2017, Gastric Cancer.

Quality of life in elderly breast cancer patients with localized disease receiving endocrine treatment: a prospective study

V. Arrazubi, R. Vera, J. Arraras, 2019, Clinical and Translational Oncology.

Spinal meningioma diagnosis based on transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA).

G. Bastarrika, R. Zárate, M. Lozano, 2013, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)

R. García-Carbonero, J. Capdevila, P. Jiménez-Fonseca, 2018, Clinical and Translational Oncology.

Stellate cells, a point of light in the dark night of pancreatic cancer

A. Viúdez, I. Hernández-García, M. Ciáurriz, 2014, British Journal of Cancer.

Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry

Alberto Carmona-Bayonas, Federico Longo, F. Rivera, 2017, British Journal of Cancer.

Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial

V. Arrazubi, L. Teijeira, R. Vera, 2019, Annals of Surgical Oncology.

Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma

J. Fernández-Irigoyen, E. Santamaría, J. Reyes, 2021, Frontiers in Medicine.

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

J. García-Foncillas, M. Ponz-Sarvisé, A. Calvo, 2007, World journal of gastroenterology.

[Intestinal pneumatosis and portomesenteric gas: a case review].

A. Alonso-Burgos, A. Viúdez, J. Aquerreta, 2007, Revista de medicina de la Universidad de Navarra.

Guidelines for diagnosis, staging and treatment of metastatic colorectal cancer by Grupo Español Multidisciplinar en Cancer Digestivo (GEMCAD)

L. Cerezo, E. Espin, J. Aparicio, 2015 .

Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study

J. Figueras, C. Montagut, J. Aparicio, 2020, Cancers.

Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study)

R. García-Carbonero, I. Matos, J. Capdevila, 2019, British Journal of Cancer.

1157O A multi-cohort phase II study of durvalumab plus tremelimumab for the treatment of patients (pts) with advanced neuroendocrine neoplasms (NENs) of gastroenteropancreatic or lung origin: The DUNE trial (GETNE 1601)

R. García-Carbonero, J. Capdevila, Á. Teulé, 2020 .

A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)

J. Herman, S. Baylin, elliot k fishman, 2016, Oncotarget.

Cytokines and Lymphoid Populations as Potential Biomarkers in Locally and Borderline Pancreatic Adenocarcinoma

J. Feliu, J. Fernández-Irigoyen, J. Castaño, 2022, Cancers.

Stereotactic body radiation therapy for liver metastasis from colorectal cancer: size matters

F. Arias, A. Viúdez, S. Pellejero, 2020, Clinical and Translational Oncology.

A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis

I. Melero, M. Rodriguez-Ruiz, F. Rotellar, 2018, Journal of Immunotherapy for Cancer.

Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.

M. Garrido, F. Longo, P. Jiménez-Fonseca, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab.

J. García-Foncillas, M. Ponz-Sarvisé, I. Gil-Aldea, 2010, Critical reviews in oncology/hematology.

Quality of life assessment by applying EORTC questionnaires to rectal cancer patients after surgery and neoadjuvant and adjuvant treatment.

R. Vera, J. Arraras, A. Viúdez, 2013, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Determinants of patient satisfaction with care in a Spanish oncology Day Hospital and its relationship with quality of life

Maite Martínez, R. Vera, J. Arraras, 2013, Psycho-oncology.

The cancer outpatient satisfaction with care questionnaire for chemotherapy, OUT-PATSAT35 CT: a validation study for Spanish patients

A. Brédart, Maite Martínez, R. Vera, 2012, Supportive Care in Cancer.

Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy

V. Valenti, I. Sola, A. Viúdez, 2011, Journal of surgical oncology.

SEOM clinical guideline thyroid cancer (2019)

E. Gallardo, T. Ramón Y Cajal, J. Capdevila, 2020, Clinical and Translational Oncology.